Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.
Saved in:
| Title: | Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases. |
|---|---|
| Authors: | Bakrania A; Toronto General Hospital Research Institute, Toronto, ON, Canada.; Ajmera Transplant Program, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Nguyen Lefebvre AT; Ajmera Transplant Program, University Health Network, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada., de Vries R; Canadian Donation and Transplantation Research Program, Toronto, ON, Canada., Laflamme MA; McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada., Jaeckel E; Ajmera Transplant Program, University Health Network, Toronto, ON, Canada.; Division of Gastroenterology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada., Hansen He H; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Radvanyi L; Ontario Institute for Cancer Research, Toronto, ON, Canada., Hedtrich S; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.; Center of Biological Design, Berlin Institute of Health at Charite - Universitatsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charite - Universitatsmedizin Berlin, Corporate member of Freie Universitat Berlin and Humboldt Universitat zu Berlin, Berlin, Germany.; Max-Delbruck Center for Molecular Medicine in the Helmholtz Associateion (MDC), Berlin, Germany., Sahay G; Department of Pharmaceutical Sciences, College of Pharmacy, Robertson Life Sciences Building, Oregon State University, Portland, OR, USA.; Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Robertson Life Sciences Building, Oregon Health and Science University, Portland, OR, USA., Blakney A; Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada., Sefton M; Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada.; Institute Biomedical Engineering, University of Toronto, Toronto, ON, Canada., Li B; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Institute Biomedical Engineering, University of Toronto, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada., Zheng G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Bhat M; Toronto General Hospital Research Institute, Toronto, ON, Canada. Mamatha.Bhat@uhn.ca.; Ajmera Transplant Program, University Health Network, Toronto, ON, Canada. Mamatha.Bhat@uhn.ca.; Division of Gastroenterology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada. Mamatha.Bhat@uhn.ca.; Department of Medical Sciences, Toronto, ON, Canada. Mamatha.Bhat@uhn.ca. |
| Source: | Communications medicine [Commun Med (Lond)] 2026 Apr 11; Vol. 6 (1). Date of Electronic Publication: 2026 Apr 11. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-664X |
|---|---|
| DOI: | 10.1038/s43856-026-01476-y |
